课题基金 / 基金详情

Screening and characterization of BMP-specific R-Smads binding proteins

Screening and characterization of BMP-specific R-Smads binding proteins
BMP 特异性 R-Smads 结合蛋白的筛选和表征
批准号:
13671554
负责人:
IMAMURA Takeshi
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

IMAMURA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bone morphogenetic proteins (BMPs), members of the transforming growth factor-β (TGF-β) superfamily, were originally identified as osteoinductive proteins in bone that induce ectopic bone and cartilage formation in vivo. BMPs bind to type I and type II serine/threonine kinase receptors, BMPR-I and II. Smad proteins play central roles in intracellular signaling by BMPs. Eight different Smad proteins have been identified in mammals, and are classified into three subgroups, i. e. receptor-regulated Smads (R-Smads), a common-partner Smad (Co-Smad), and inhibitory Smads (I-Smads). BMP-specific R-Smads, Smads 1,5 and 8, transiently and directly interact with activated BMPR-Is, and become phosphorylated. Smad1/5/8 then form heteromeric complexes with Co-Smad, Smad4, and translocate into the nucleus where they regulate transcription of various target genes. In contrast, I-Smads, including Smad6 and Smad7, stably bind to BMPR-Is and compete with Smad1/5/8 for activation, resulting in inhibition of BMP signaling.In this project, we examined the function of Smad ubiquitin regulatory factor(Smurf) 1 as a Smad binding protein. Smurf1 was originally identified as an E3 ubiquitin ligase for Smad1/5. We demonstrated that Smurf1 associates with type I receptors for BMPs through the I-Smads, and induced their ubiquitination and degradation. Smurf1 thus controls BMP signaling with and without I-Smads through multiple mechanisms.Next, we clarified the mechanism of nuclear export and membrane localization of Smurf1-I-Smad complex. Smurf1 binds to CRM1, and Smurf1-I-Smad complex translocates from the nucleus to the cytoplasm. Then Smurf1-I-Smad complex locates to cell membrane through C2 domain of Smurf1.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K: "The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling"J Cell Biol.. 155. 1017-1028 (2001)
Hanyu A、Ishidou Y、Ebisawa T、Shimanuki T、Imamura T、Miyazono K:“Smad7 的 N 结构域对于转化生长因子-β 信号传导的特异性抑制至关重要”J Cell Biol.. 155. 1017-1028 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H: "Glypican-3, ova-expressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling."Int J Cancer.. 103. 455-465 (2003)
Midorikawa Y、Ishikawa S、Iwanari H、Imamura T、Sakamoto H、Miyazono K、Kodama T、Makuuchi M、Aburatani H:“肝细胞癌中 ova 表达的 Glypican-3,调节 FGF2 和 BMP-7 信号传导。”Int J
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishihara, A.et al.: "Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary Hypertension"Mol Biol Cell. 13. 3055-3063 (2002)
Nishihara, A.等人:“原发性肺动脉高压患者中发现的骨形态发生蛋白受体-II 突变体的功能异质性”Mol Biol Cell。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K: "Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation"J Biol Chem.. 276. 12477-12480 (2001)
Ebisawa T、Fukuchi M、Murakami G、Chiba T、Tanaka K、Imamura T、Miyazono K:“Smurf1 通过 Smad7 与转化生长因子-β I 型受体相互作用,并诱导受体降解”J Biol Chem.. 276. 12477-12480
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    The mechanisms of Galectin3-induced stem cell dysfunction and the effects of anti-galectin3 therapy
    • 批准号:
      19H03378
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2019
    • 负责人:
      IMAMURA Takeshi
    • 依托单位:
    Microscale processes in the Venus atmosphere revealed by radio occultation
    • 批准号:
      24540482
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2012
    • 负责人:
      IMAMURA Takeshi
    • 依托单位:
    Effects of insulin resistance-related factors on the stem cell functions in vivo.
    • 批准号:
      23390056
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2011
    • 负责人:
      IMAMURA Takeshi
    • 依托单位:
    Development of advanced fluorescent imaging systems for the study of bone remodeling
    • 批准号:
      23390368
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2011
    • 负责人:
      IMAMURA Takeshi
    • 依托单位:
    国内基金
    海外基金
    新型超声空化调控体系靶向TGF-β/Smads通路介导乳腺癌放疗增敏的机制研究
    • 批准号:
      2026JJ82656
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      罗丹
    • 依托单位:
    TGF-β/Smads信号通路介导羟脯氨酸调控草鱼肌肉I型胶原蛋白合成的分子 机制研究
    • 批准号:
      2025JJ70022
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      唐建洲
    • 依托单位:
    FSGS6 靶向COL11A1调控SMADs核易位在肺癌早期复发转移中的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吴琼
    • 依托单位:
    人参皂甙Rg3通过TGFβ/Smads信号通路对胰腺癌细胞血管生成拟态生成的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郭敬强
    • 依托单位: